![A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523422006870-ga1.jpg)
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
![Three‐finger proteins from snakes and humans acting on nicotinic receptors: Old and new - Tsetlin - 2021 - Journal of Neurochemistry - Wiley Online Library Three‐finger proteins from snakes and humans acting on nicotinic receptors: Old and new - Tsetlin - 2021 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/dc2535dd-cef7-4912-8936-3281a13dd32b/jnc15123-fig-0003-m.jpg)
Three‐finger proteins from snakes and humans acting on nicotinic receptors: Old and new - Tsetlin - 2021 - Journal of Neurochemistry - Wiley Online Library
![Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0028390820304093-fx1.jpg)
Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis - ScienceDirect
![In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20200227120957045-0270:S0924270819000474:S0924270819000474_fig2.png?pub-status=live)
In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core
![The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS2633289221000077/resource/name/S2633289221000077_figAb.png?pub-status=live)
The G protein-first activation mechanism of opioid receptors by Gi protein and agonists | QRB Discovery | Cambridge Core
![Anticonvulsant activity of pentazocine and its probable mechanism: An Experimental Pharmacological Study: Panchaksharimath, Praveen, Devaru, Siddappa, Singh, Shailender: 9783848493692: Amazon.com: Books Anticonvulsant activity of pentazocine and its probable mechanism: An Experimental Pharmacological Study: Panchaksharimath, Praveen, Devaru, Siddappa, Singh, Shailender: 9783848493692: Amazon.com: Books](https://m.media-amazon.com/images/W/MEDIAX_792452-T2/images/I/61ulnBECzFL._AC_UF1000,1000_QL80_.jpg)
Anticonvulsant activity of pentazocine and its probable mechanism: An Experimental Pharmacological Study: Panchaksharimath, Praveen, Devaru, Siddappa, Singh, Shailender: 9783848493692: Amazon.com: Books
![Study targets kappa opioid receptor to develop more effective drugs for pain management | Anesthesiology | Washington University School of Medicine in St. Louis Study targets kappa opioid receptor to develop more effective drugs for pain management | Anesthesiology | Washington University School of Medicine in St. Louis](https://anesthesiology.wustl.edu/wp-content/uploads/2023/03/Tao-Che.jpg)
Study targets kappa opioid receptor to develop more effective drugs for pain management | Anesthesiology | Washington University School of Medicine in St. Louis
![Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor | Nature Communications Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-023-43718-w/MediaObjects/41467_2023_43718_Fig1_HTML.png)
Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor | Nature Communications
![Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ff659c0a-df99-4a5e-8df9-c1e1925ea7d0/jcpt12404-fig-0001-m.jpg)
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
![The dynorphin/kappa opioid receptor mediates adverse immunological and behavioral outcomes induced by repetitive blast trauma | Journal of Neuroinflammation | Full Text The dynorphin/kappa opioid receptor mediates adverse immunological and behavioral outcomes induced by repetitive blast trauma | Journal of Neuroinflammation | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12974-022-02643-3/MediaObjects/12974_2022_2643_Fig1_HTML.png)
The dynorphin/kappa opioid receptor mediates adverse immunological and behavioral outcomes induced by repetitive blast trauma | Journal of Neuroinflammation | Full Text
![Brain Sciences | Free Full-Text | Shared Mechanisms of GABAergic and Opioidergic Transmission Regulate Corticolimbic Reward Systems and Cognitive Aspects of Motivational Behaviors Brain Sciences | Free Full-Text | Shared Mechanisms of GABAergic and Opioidergic Transmission Regulate Corticolimbic Reward Systems and Cognitive Aspects of Motivational Behaviors](https://www.mdpi.com/brainsci/brainsci-13-00815/article_deploy/html/images/brainsci-13-00815-g001.png)
Brain Sciences | Free Full-Text | Shared Mechanisms of GABAergic and Opioidergic Transmission Regulate Corticolimbic Reward Systems and Cognitive Aspects of Motivational Behaviors
![Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor | Nature Communications Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-023-43718-w/MediaObjects/41467_2023_43718_Fig2_HTML.png)
Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor | Nature Communications
![In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20200227120957045-0270:S0924270819000474:S0924270819000474_tab1.png?pub-status=live)
In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core
![Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.9b00195/asset/images/large/cn-2019-00195v_0008.jpeg)
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
![In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20200227120957045-0270:S0924270819000474:S0924270819000474_tab3.png?pub-status=live)
In major depression, increased kappa and mu opioid receptor levels are associated with immune activation | Acta Neuropsychiatrica | Cambridge Core
![Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor | Nature Communications Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-023-43718-w/MediaObjects/41467_2023_43718_Fig5_HTML.png)
Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor | Nature Communications
![Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.7b00109/asset/images/large/jm-2017-00109c_0010.jpeg)